Since the introduction of new biologic agents and intensive treatment strategies that aim to tightly control disease activity, clinical remission has become a realistic target in patients with rheumatoid arthritis. Once patients are in continuous remission, however, is it realistic to consider withdrawing DMARD therapy?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Barriers to clinical remission in severe asthma
Respiratory Research Open Access 24 April 2024
-
Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood test
Scientific Reports Open Access 04 May 2022
-
Remission in Rheumatoid Arthritis
Current Rheumatology Reports Open Access 10 August 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
van Vollenhoven, R. F. Treatment of rheumatoid arthritis: state of the art. Nat. Rev. Rheumatol. 5, 531–541 (2009).
Bakker, M. F., Jacobs, J. W. G., Verstappen, S. M. M & Bijlsma, J. W. J. Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann. Rheum. Dis. 66 (Suppl. 3), iii56–iii60 (2007).
Mader, R. & Keystone, E. Optimizing treatment with biologics. J. Rheumatol. 80 (Suppl.), 16–24 (2007).
Combe, B. et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 66, 34–45 (2007).
Tiippana-Kinnunen, T., Paimela, L., Kautiainen, H., Laasonen, L. & Leirisalo-Repo, M. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up. Scand. J. Rheumatol. doi:10.1080/03009740903042394.
Pinals, R. S., Masi, A. T. & Larsen, R. A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 24, 1308–1315 (1981).
ten Wolde, S. et al. Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet 347, 347–352 (1996).
van der Kooij, S. M. et al. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Ann. Rheum. Dis. 68, 914–921 (2009).
van der Woude, D. et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis. Results from two large early arthritis cohorts. Arthritis Rheum. 60, 2262–2271 (2009).
Acknowledgements
This work was supported by the MASTERSWITCH Integrated Project, which is funded by the Eurpoean Union under the Seventh Framework Program (FP7).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Goekoop-Ruiterman, Y., Huizinga, T. Can we achieve true drug-free remission in patients with RA?. Nat Rev Rheumatol 6, 68–70 (2010). https://doi.org/10.1038/nrrheum.2009.253
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2009.253